Journal article
Effects of basal insulin glargine and omega‐3 on lower limb arterial disease outcome in patients with dysglycaemia: An analysis of the Outcome Reduction with an Initial Glargine INtervention (ORIGIN) trial
Abstract
The impact of insulin or omega-3 supplements on the incidence and progression of peripheral artery disease (PAD) in patients with dysglycaemia has not been well studied. The Outcome Reduction with an Initial Glargine INtervention (ORIGIN) trial randomized participants with dysglycaemia and cardiovascular risk factors to titrated insulin glargine vs standard care, and to either 1 g of omega-3 per day or placebo. We assessed incident PAD, defined …
Authors
Dagenais GR; Jung H; Bogaty P; Bosch J; Yusuf S; Gerstein HC
Journal
Diabetes Obesity and Metabolism, Vol. 21, No. 6, pp. 1502–1505
Publisher
Wiley
Publication Date
6 2019
DOI
10.1111/dom.13674
ISSN
1462-8902